Skip to content

Nanograb

YC S23 · Active · Deliver genes to any cell with AI

Competitors

Adjacent

Also from S23 in AI

All of S23

About Nanograb

Nanograb is a computational drug discovery company that uses AI to create novel targeted non-viral gene therapy vectors. Our platform designs unique combinations of small peptide binders attached to nanoparticles to safely deliver genetic medicines to specific cells and tissues in the body at scale.

YC batch
S23 · Summer 2023
Status, per YC
Active
Category
AI
Team size
5
Location
London, England, United Kingdom
Checked
33m ago

YC tags: AI-powered Drug Discovery, Nanomedicine, Biotech, Drug Delivery, Therapeutics

Nanograb in S23: 220 companies, 77% AI

Nanograb: questions

Which YC batch was Nanograb in?

Nanograb was in Y Combinator's Summer 2023 batch (S23).

Is Nanograb still active?

Y Combinator lists Nanograb as active.

Where is Nanograb based?

Nanograb lists London, England, United Kingdom as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.